Search Results
Using Patient Specific iPSC-Cardiomyocytes for Disease Modeling
Modeling Barth syndrome using patient-specific, iPSC-derived cardiomyocytes
Diabetic Cardiomyopathy Modeling & Screening with iPSC Cardiomyocytes
Generation of induced pluripotent stem cell-derived cardiomyocytes for disease modeling
SPS 2018: Implementing Human iPSC-derived Cells in Early Safety Assessment & Disease Modeling
Differentiation of human pluripotent stem cells into atrial and ventricular cardiomyocyte subtypes
PSC Cardiomyocyte Differentiation Kit – PSCs to cardiomyocytes in three steps
iPSC derived Cardiomyocytes for Predicting and Removing Drug Cardiotoxicity - Mark Mercola
K. L. Laugwitz - Human iPSC models of cardiac disease
Heart disease in a dish: Human iPSC-derived multicellular cardiac organoids
Human iPSC-based disease modeling and therapeutic development
Webinar: Using Human Cardiomyocytes in Phenotypic Screens and Target Verification
